应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ALC 爱尔康
休市中 05-31 16:00:00 EDT
89.13
+0.78
+0.88%
盘后
89.13
+0.00
0.00%
16:00 EDT
最高
89.71
最低
88.66
成交量
100.84万
今开
88.99
昨收
88.35
日振幅
1.19%
总市值
440.66亿
流通市值
439.79亿
总股本
4.94亿
成交额
8,984万
换手率
0.20%
流通股本
4.93亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
爱尔康人工晶体家族旗下8款产品集采中标 正在推进产品落地
中国网财经 · 05-31 11:56
爱尔康人工晶体家族旗下8款产品集采中标 正在推进产品落地
爱尔康2024财年第一财季实现净利润2.48亿美元,同比增加42.53%
自选股智能写手 · 05-20
爱尔康2024财年第一财季实现净利润2.48亿美元,同比增加42.53%
希玛眼科(03309.HK)已出售Belkin Vision Ltd.的股权予爱尔康
格隆汇资讯 · 05-16
希玛眼科(03309.HK)已出售Belkin Vision Ltd.的股权予爱尔康
富国银行:维持Alcon(ALC.US)评级,由增持调整至增持评级,目标价由89.00美元调整至94
智通财经 · 05-16
富国银行:维持Alcon(ALC.US)评级,由增持调整至增持评级,目标价由89.00美元调整至94
爱尔康盘中异动 急速上涨9.97%
自选股智能写手 · 05-14
爱尔康盘中异动 急速上涨9.97%
Needham:重申Alcon(ALC.US)评级,由买入调整至买入评级, 目标价98.00美元。
智通财经 · 05-14
Needham:重申Alcon(ALC.US)评级,由买入调整至买入评级, 目标价98.00美元。
爱尔康2023财年实现净利润9.74亿美元,同比增加190.75%
自选股智能写手 · 03-04
爱尔康2023财年实现净利润9.74亿美元,同比增加190.75%
投行Baird看好2024年医疗技术股跑赢大盘,首选爱尔康(ALC.US)和波士顿科学(BSX.US)等公司
智通财经网 · 01-16
投行Baird看好2024年医疗技术股跑赢大盘,首选爱尔康(ALC.US)和波士顿科学(BSX.US)等公司
爱尔康集采杀价震惊业内,高端人工晶体从2.3万降至9000元后与海外平价
华尔街见闻 · 2023-12-28
爱尔康集采杀价震惊业内,高端人工晶体从2.3万降至9000元后与海外平价
眼科龙头爱尔康高端人工晶体集采价格大跳水,双焦点产品比国产品牌低约千元
每日经济新闻 · 2023-12-28
眼科龙头爱尔康高端人工晶体集采价格大跳水,双焦点产品比国产品牌低约千元
投行Baird评出2024年医疗技术首选 看好爱尔康和Axonics
智通财经 · 2023-12-26
投行Baird评出2024年医疗技术首选 看好爱尔康和Axonics
投行Baird评出2024年医疗技术首选,看好爱尔康(ALC.US)和Axonics(AXNX.US)
智通财经 · 2023-12-25
投行Baird评出2024年医疗技术首选,看好爱尔康(ALC.US)和Axonics(AXNX.US)
暂无数据
公司概况
公司名称:
爱尔康
所属市场:
NYSE
上市日期:
--
主营业务:
Alcon Inc.最初于1971年在瑞士注册成立。Alcon是一家以研发为主导的全球医疗专业公司,主要专注于眼部护理。该公司开发,生产和销售药品,手术设备和设备以及消费者眼部护理产品。该公司广泛的产品系列是眼科行业中最强大的产品组合之一,在所有主要产品类别中都拥有高质量和技术先进的产品。该公司相信它拥有全球任何公司眼科研究和开发的最大承诺。
发行价格:
--
{"stockData":{"symbol":"ALC","market":"US","secType":"STK","nameCN":"爱尔康","latestPrice":89.13,"timestamp":1717185600000,"preClose":88.35,"halted":0,"volume":1008427,"hourTrading":{"tag":"盘后","latestPrice":89.13,"preClose":89.13,"latestTime":"16:00 EDT","volume":2605,"amount":232183.65,"timestamp":1717185616007},"delay":0,"floatShares":493423955,"shares":494400000,"eps":2.109637,"marketStatus":"休市中","marketStatusCode":7,"change":0.78,"latestTime":"05-31 16:00:00 EDT","open":88.99,"high":89.71,"low":88.66,"amount":89837095.797855,"amplitude":0.011885,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.109637,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1717401600000},"adr":0,"adjPreClose":88.35,"adrRate":0,"dividendRate":0.003198,"preHourTrading":{"tag":"盘前","latestPrice":89.18,"preClose":88.35,"latestTime":"09:12 EDT","volume":1058,"amount":94126.06397199999,"timestamp":1717161157952},"postHourTrading":{"tag":"盘后","latestPrice":89.13,"preClose":89.13,"latestTime":"16:00 EDT","volume":2605,"amount":232183.65,"timestamp":1717185616007},"volumeRatio":1.209994110772452},"requestUrl":"/m/hq/s/ALC/tweets","defaultTab":"tweets","newsList":[{"id":"2439379669","title":"爱尔康人工晶体家族旗下8款产品集采中标 正在推进产品落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2439379669","media":"中国网财经","top":-1,"share":"https://www.laohu8.com/m/news/2439379669?lang=zh_cn&edition=full","pubTime":"2024-05-31 11:56","pubTimestamp":1717127760,"startTime":"0","endTime":"0","summary":"据悉,在2023年的第四批国家组织高值医用耗材集采中,爱尔康人工晶体家族旗下包括AcrySof IQ Vivity焕采及AcrySof IQ PanOptix焕全在内的8款人工晶体产品中标。目前,爱尔康正在为推进国家集采后的产品落地各项事宜积极准备,落实产品生产、质控、运输的各个细节,确保产品供应;同时通过线上线下培训,保障人工晶体集采后的进院,被更多患者使用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405311219509f08c025&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405311219509f08c025&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2436319811","title":"爱尔康2024财年第一财季实现净利润2.48亿美元,同比增加42.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436319811","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436319811?lang=zh_cn&edition=full","pubTime":"2024-05-20 00:09","pubTimestamp":1716134951,"startTime":"0","endTime":"0","summary":"3月31日,爱尔康公布财报,公告显示公司2024财年第一财季净利润为2.48亿美元,同比增加42.53%;其中营业收入为24.59亿美元,同比增加4.55%,每股基本收益为0.50美元。机构评级:截至2024年3月31日,当前有26家机构对爱尔康目标价做出预测,其中目标均价为95.46美元,其中最低目标价为65.00美元,最高目标价为105.00美元。爱尔康拥有世界上最大的眼科手术设备安装基地之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520000921877ab34c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520000921877ab34c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435492670","title":"希玛眼科(03309.HK)已出售Belkin Vision Ltd.的股权予爱尔康","url":"https://stock-news.laohu8.com/highlight/detail?id=2435492670","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2435492670?lang=zh_cn&edition=full","pubTime":"2024-05-16 21:22","pubTimestamp":1715865738,"startTime":"0","endTime":"0","summary":"格隆汇5月16日丨希玛眼科公告,公司全资附属公司香港(国际)眼科医疗集团有限公司已出售其于Belkin Vision Ltd.的股权予Alcon Pharmaceuticals Ltd(爱尔康),其于2023年12月31日的账面值为23.3百万港元,并分类为按公平值计入其他全面收入的金融资产。出售事项完成前,香港眼科医疗持有出售公司约10.7%股权或按悉数摊薄基准计算的8.6%股权,而香港眼科医疗于2020年5月已投资于出售公司。完成后,香港眼科医疗将不再持有出售公司的任何权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405162122248770a288&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405162122248770a288&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435613089","title":"富国银行:维持Alcon(ALC.US)评级,由增持调整至增持评级,目标价由89.00美元调整至94","url":"https://stock-news.laohu8.com/highlight/detail?id=2435613089","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435613089?lang=zh_cn&edition=full","pubTime":"2024-05-16 09:20","pubTimestamp":1715822446,"startTime":"0","endTime":"0","summary":"富国银行 :维持Alcon(ALC.US)评级,由增持调整至增持评级,目标价由89.00美元调整至94.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240516093720876e5369&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240516093720876e5369&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435519616","title":"爱尔康盘中异动 急速上涨9.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435519616","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435519616?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:33","pubTimestamp":1715693589,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时33分,爱尔康股票出现异动,股价大幅上涨9.97%。爱尔康股票所在的医疗设备行业中,整体涨幅为0.67%。爱尔康拥有世界上最大的眼科手术设备安装基地之一。消息层面,截至21时33分,《Needham:重申Alcon评级,由买入调整至买入评级, 目标价98.00美元。》资讯为影响爱尔康的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142133098768ef4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142133098768ef4b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435960295","title":"Needham:重申Alcon(ALC.US)评级,由买入调整至买入评级, 目标价98.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435960295","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435960295?lang=zh_cn&edition=full","pubTime":"2024-05-14 18:26","pubTimestamp":1715682363,"startTime":"0","endTime":"0","summary":"Needham:重申Alcon(ALC.US)评级,由买入调整至买入评级, 目标价98.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051418260787684ae9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051418260787684ae9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416629909","title":"爱尔康2023财年实现净利润9.74亿美元,同比增加190.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416629909","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416629909?lang=zh_cn&edition=full","pubTime":"2024-03-04 00:16","pubTimestamp":1709482582,"startTime":"0","endTime":"0","summary":"12月31日,爱尔康公布财报,公告显示公司2023财年净利润为9.74亿美元,同比增加190.75%;其中营业收入为94.55亿美元,同比增加8.47%,每股基本收益为1.98美元。机构评级:截至2023年12月31日,当前有25家机构对爱尔康目标价做出预测,其中目标均价为91.59美元,其中最低目标价为65.00美元,最高目标价为104.00美元。爱尔康拥有世界上最大的眼科手术设备安装基地之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040016278afdcf81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040016278afdcf81&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2403078063","title":"投行Baird看好2024年医疗技术股跑赢大盘,首选爱尔康(ALC.US)和波士顿科学(BSX.US)等公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2403078063","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2403078063?lang=zh_cn&edition=full","pubTime":"2024-01-16 07:10","pubTimestamp":1705360200,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,投行Baird表示,在经历了三年的表现不佳之后,预计医疗科技股将在2024年跑赢大盘,但对牙科和美容市场近期仍持谨慎态度。Baird说,正因为如此,它正在改变对牙科群体的看法,从“战术上的积极到战术上的中立,甚至稍微消极”。尽管如此,Baird提醒InMode的投资者“做好准备,2024年的最终指引可能会要求今年的收入相对于2023年几乎没有增长。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011607130987bea0ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011607130987bea0ae&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2394111957","title":"爱尔康集采杀价震惊业内,高端人工晶体从2.3万降至9000元后与海外平价","url":"https://stock-news.laohu8.com/highlight/detail?id=2394111957","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2394111957?lang=zh_cn&edition=full","pubTime":"2023-12-28 19:13","pubTimestamp":1703762030,"startTime":"0","endTime":"0","summary":"爱尔康降价后三焦点人工晶体比主要竞争对手之一的蔡司低40%,双焦点人工晶体至比国产的爱博诺德低约1000元,或将颠覆国内人工晶体市场,行业格局有望迎来大洗牌。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/14a283a3-3faf-4481-a14d-ce03087d57b7.png?imageView2/1/w/340/h/340","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/14a283a3-3faf-4481-a14d-ce03087d57b7.png?imageView2/1/w/340/h/340"],"rights":{"source":"wallstreetcn_api","url":"https://wallstreetcn.com/articles/3705228","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3705228","is_publish_highlight":false,"gpt_icon":0},{"id":"2394798863","title":"眼科龙头爱尔康高端人工晶体集采价格大跳水,双焦点产品比国产品牌低约千元","url":"https://stock-news.laohu8.com/highlight/detail?id=2394798863","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2394798863?lang=zh_cn&edition=full","pubTime":"2023-12-28 13:03","pubTimestamp":1703739815,"startTime":"0","endTime":"0","summary":"每经记者:李宣璋每经编辑:陈旭每经讯 第四批高值耗材集采结果震惊业界:爱尔康作为全球眼科龙头,将自家三焦点人工晶体价格从2.3万元降至8996元,这一价格比主要竞争对手之一的蔡司低40%!在双焦点人工晶体方面,爱尔康的报价也成为全场最低。作为进口品牌,其1796元的价格,甚至比国产的爱博诺德还低了约1000元。每日经济新闻","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231228130413818291f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231228130413818291f7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2394249492","title":"投行Baird评出2024年医疗技术首选 看好爱尔康和Axonics","url":"https://stock-news.laohu8.com/highlight/detail?id=2394249492","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2394249492?lang=zh_cn&edition=full","pubTime":"2023-12-26 21:13","pubTimestamp":1703596439,"startTime":"0","endTime":"0","summary":"出于类似的原因,Baird也看好隐形眼镜制造商库柏,但相比库柏外科,Baird更看好爱尔康的外科。Baird认为,爱尔康2024年的利润率扩张幅度将大于库珀。至于波士顿科学,Baird认为新产品的推出将推动公司收入在2025年加速增长,因此利润率的提高将提升估值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2023/12/26211338887376.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2394382542","title":"投行Baird评出2024年医疗技术首选,看好爱尔康(ALC.US)和Axonics(AXNX.US)","url":"https://stock-news.laohu8.com/highlight/detail?id=2394382542","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2394382542?lang=zh_cn&edition=full","pubTime":"2023-12-25 08:00","pubTimestamp":1703462428,"startTime":"0","endTime":"0","summary":"投行Baird评出2024年医疗技术首选,看好爱尔康和Axonics智通财经APP获悉,投行Baird选择爱尔康、史赛克、库珀医疗、Axonics和波士顿科学作为其2024年的首选医疗科技股。出于类似的原因,Baird也看好隐形眼镜制造商库柏,但相比库柏外科,Baird更看好爱尔康的外科。Baird认为,爱尔康2024年的利润率扩张幅度将大于库珀。Baird表示,Inspire Medical Systems和Intuitive Surgical因估值和“近期潜在负面新闻风险”落选其首选名单。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1044774.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alcon.com","stockEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":0.135},{"period":"3month","weight":0.0276},{"period":"6month","weight":0.1751},{"period":"1year","weight":0.1337},{"period":"ytd","weight":0.1409}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":0.054},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.1487},{"period":"1year","weight":0.2502},{"period":"ytd","weight":0.1095}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alcon Inc.最初于1971年在瑞士注册成立。Alcon是一家以研发为主导的全球医疗专业公司,主要专注于眼部护理。该公司开发,生产和销售药品,手术设备和设备以及消费者眼部护理产品。该公司广泛的产品系列是眼科行业中最强大的产品组合之一,在所有主要产品类别中都拥有高质量和技术先进的产品。该公司相信它拥有全球任何公司眼科研究和开发的最大承诺。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.013735},{"month":2,"riseRate":0.6,"avgChangeRate":0.005925},{"month":3,"riseRate":0.6,"avgChangeRate":-0.019148},{"month":4,"riseRate":0.6,"avgChangeRate":-0.005889},{"month":5,"riseRate":0.666667,"avgChangeRate":0.065443},{"month":6,"riseRate":0.6,"avgChangeRate":-0.005365},{"month":7,"riseRate":0.8,"avgChangeRate":0.036185},{"month":8,"riseRate":0.4,"avgChangeRate":-0.011043},{"month":9,"riseRate":0,"avgChangeRate":-0.052099},{"month":10,"riseRate":0.6,"avgChangeRate":0.003855},{"month":11,"riseRate":0.6,"avgChangeRate":0.039784},{"month":12,"riseRate":0.8,"avgChangeRate":0.037954}],"exchange":"NYSE","name":"爱尔康","nameEN":"Alcon Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱尔康(ALC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱尔康(ALC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱尔康,ALC,爱尔康股票,爱尔康股票老虎,爱尔康股票老虎国际,爱尔康行情,爱尔康股票行情,爱尔康股价,爱尔康股市,爱尔康股票价格,爱尔康股票交易,爱尔康股票购买,爱尔康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱尔康(ALC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱尔康(ALC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}